17-63917348-G-C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_000515.5(GH1):​c.615C>G​(p.Ile205Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000512 in 1,614,012 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00052 ( 6 hom. )

Consequence

GH1
NM_000515.5 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 1.01

Publications

8 publications found
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
GH1 Gene-Disease associations (from GenCC):
  • isolated growth hormone deficiency type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type II
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type IB
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short stature due to growth hormone qualitative anomaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07723981).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000394 (60/152288) while in subpopulation AFR AF = 0.00077 (32/41572). AF 95% confidence interval is 0.000559. There are 0 homozygotes in GnomAd4. There are 33 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 6 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000515.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GH1
NM_000515.5
MANE Select
c.615C>Gp.Ile205Met
missense
Exon 5 of 5NP_000506.2
GH1
NM_022559.4
c.570C>Gp.Ile190Met
missense
Exon 5 of 5NP_072053.1
GH1
NM_022560.4
c.495C>Gp.Ile165Met
missense
Exon 4 of 4NP_072054.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GH1
ENST00000323322.10
TSL:1 MANE Select
c.615C>Gp.Ile205Met
missense
Exon 5 of 5ENSP00000312673.5
ENSG00000285947
ENST00000647774.1
c.891C>Gp.Ile297Met
missense
Exon 8 of 8ENSP00000497443.1
GH1
ENST00000458650.6
TSL:1
c.570C>Gp.Ile190Met
missense
Exon 5 of 5ENSP00000408486.2

Frequencies

GnomAD3 genomes
AF:
0.000394
AC:
60
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000772
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000418
AC:
105
AN:
251244
AF XY:
0.000523
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000528
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000524
AC:
766
AN:
1461724
Hom.:
6
Cov.:
31
AF XY:
0.000554
AC XY:
403
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.00122
AC:
41
AN:
33472
American (AMR)
AF:
0.000447
AC:
20
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.000742
AC:
64
AN:
86246
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53418
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5762
European-Non Finnish (NFE)
AF:
0.000541
AC:
602
AN:
1111898
Other (OTH)
AF:
0.000497
AC:
30
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
55
110
165
220
275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000394
AC:
60
AN:
152288
Hom.:
0
Cov.:
32
AF XY:
0.000443
AC XY:
33
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000770
AC:
32
AN:
41572
American (AMR)
AF:
0.000196
AC:
3
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68020
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000335
Hom.:
0
Bravo
AF:
0.000442
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000461
AC:
56
EpiCase
AF:
0.000436
EpiControl
AF:
0.000889

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Nov 29, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a decreased ability to activate ERK, but show normal JAK/STAT pathway activation, normal secretion, and normal binding characteristics (Lewis et al., 2004); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25557026, 28498917, 15001589)

Nov 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 205 of the GH1 protein (p.Ile205Met). This variant is present in population databases (rs148474991, gnomAD 0.07%). This missense change has been observed in individual(s) with clinical features of GH1-related conditions (PMID: 15001589, 25557026). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Ile179Met. ClinVar contains an entry for this variant (Variation ID: 500833). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects GH1 function (PMID: 15001589). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Apr 30, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Sep 23, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GH1 c.615C>G (p.Ile205Met) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00042 in 251244 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in GH1 causing Idiopathic Growth Hormone Deficiency (0.00042 vs 0.011), allowing no conclusion about variant significance. The variant, c.615C>G, has been reported in the literature in individuals affected with GH1-related disorders (Lewis_2004, Fritez_2015, Kirkgoz_2023), however, in one of the reported families the variant did not cosegregate with the phenotype (Lewis_2004). These data do not allow clear conclusions about variant significance. One of these publications also reported experimental evidence evaluating an impact on protein function, demonstrating normal secretion, and receptor binding with normal JAK/STAT pathway activation for the variant protein, however, the activation of ERK pathway was reduced to about half (Lewis_2004). The impaired ability to activate ERK does not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 2014261, 25557026, 10462528, 34426522, 37948564, 15001589, 28498917, 18488018, 34091447). ClinVar contains an entry for this variant (Variation ID: 500833). Based on the evidence outlined above, the variant was classified as uncertain significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
9.7
DANN
Benign
0.83
DEOGEN2
Uncertain
0.59
D
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.49
T
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.077
T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
0.69
N
PhyloP100
1.0
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.56
Sift
Benign
0.26
T
Sift4G
Benign
0.24
T
Polyphen
0.0070
B
Vest4
0.48
MVP
0.69
MPC
0.13
ClinPred
0.0094
T
GERP RS
-1.0
Varity_R
0.65
gMVP
0.46
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148474991; hg19: chr17-61994708; COSMIC: COSV60112201; COSMIC: COSV60112201; API